Drug Repurposing in Thyroid Carcinoma: a Feasibility Trial
Drug Repurposing in Thyroid Carcinoma: a Feasibility Trial
Active, not recruiting · NCT07485569 · Registry updated 2026-09-02Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Drug Repurposing in Thyroid Carcinoma: a Feasibility Trial | Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, carcinoma, differentiated thyroid carcinoma, endocrine system disorder, epithelial neoplasm, malignant endocrine neoplasm, neoplasm, poorly differentiated thyroid gland carcinoma, thyroid gland disorder, thyroid gland undifferentiated (anaplastic) carcinoma, thyroid tumor | Active, not recruiting | Phase 1 | 2026-09-02 | NCT07485569 |
4 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| EU Horizon | 3 |
| Horizon Europe | 5 |
| Maastricht University | 40 |
| Radboud University Medical Center | 216 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Radboudumc | Nijmegen | Netherlands | 38 |